Ninlaro
Term · Oncology and biomedicine · MLC-T-ONC-005839
A drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who received at least one other anticancer treatment. It is also being studied in the treatment of other types of cancer. Ninlaro blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called ixazomib citrate.
| Identifier | MLC-T-ONC-005839 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ixazomib citrate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005839",
"term": "Ninlaro",
"field": "Oncology and biomedicine",
"definition": "A drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who received at least one other anticancer treatment. It is also being studied in the treatment of other types of cancer. Ninlaro blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called ixazomib citrate.",
"synonyms": [
"ixazomib citrate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ninlaro/"
}
Record 11,837 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.